Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a class of oral medications initially developed and FDA-approved as antidiabetic drugs to lower blood sugar in adults with type 2 diabetes. Subsequent clinical trials revealed significant benefits for kidney health...
Recent Comments